자료유형  

 학위논문

Control Number  

0016933180

International Standard Book Number  

9798380306935

Dewey Decimal Classification Number  

362.1

Main Entry-Personal Name  

Mohamed, Wafick K.

Publication, Distribution, etc. (Imprint  

[S.l.] : The University of Alabama at Birmingham., 2023

Publication, Distribution, etc. (Imprint  

Ann Arbor : ProQuest Dissertations & Theses, 2023

Physical Description  

1 online resource(117 p.)

General Note  

Source: Dissertations Abstracts International, Volume: 85-03, Section: B.

General Note  

Advisor: Borkowski, Nancy.

Dissertation Note  

Thesis (D.Sc.)--The University of Alabama at Birmingham, 2023.

Restrictions on Access Note  

This item must not be sold to any third party vendors.

Summary, Etc.  

요약This study examined the relationship between CEO tenure, sex, level of education, and organizational performance across 229 U.S. publicly traded pharmaceutical and biopharmaceutical companies. The Upper Echelons Theory was used to guide this research on how CEO characteristics could impact organizational performance. Fifteen hypotheses were developed and tested to evaluate the statistically significant relationship between CEO tenure, sex, level of education, and the organizational performance demonstrated in the abnormal stock return valuation and the number of FDA-approved drug products in clinical trial phases (phase 1, 2, and 3) for each company.This quantitative, non-experimental, and cross-sectional study was completed by conducting Multiple Linear Regression analysis and Negative Binomial Regression analysis to quantitative secondary data representing CEOs' characteristics and their organizations.Study findings suggest that the length of CEO tenure had a positive statistically significant relationship with organizational performance. Our results showed that as a CEO's tenure increases by one year, the abnormal stock return increases by 0.92%, and the number of drug products in the pipeline in phase 3 increases by a factor of 1.03 (3%). CEO sex and level of education did not indicate any statistically significant relationship with the abnormal stock return or the number of FDA-approved drug products in clinical trial phases (phases 1, 2, and 3).

Subject Added Entry-Topical Term  

Health care management.

Index Term-Uncontrolled  

Chief Executive Officers

Index Term-Uncontrolled  

Organizational outcomes

Index Term-Uncontrolled  

Organizational performance

Index Term-Uncontrolled  

Biopharmaceutical companies

Added Entry-Corporate Name  

The University of Alabama at Birmingham Administration/Health Services

Host Item Entry  

Dissertations Abstracts International. 85-03B.

Host Item Entry  

Dissertation Abstract International

Electronic Location and Access  

로그인을 한후 보실 수 있는 자료입니다.

Control Number  

joongbu:639435